Head And Neck Cancer Stories
-
An Immunotherapy Drug Extends Life For Patients With Head And Neck Cancers
Used in combination with chemo, the immunotherapy drug Nivolumab has had promising results in treating tumors in advanced head and neck cancer patients. -
15.5 Million Americans Are Cancer Survivors
As of Jan. 1, 2016, more than 15.5 million Americans have a history of cancer; in 2026, this number will reach more than 20 million. -
Bristol-Myers' Opdivo Extends Survival In Head And Neck Cancer -Study
Bristol-Myers Squibb's cancer immunotherapy drug, Opdivo, helped advanced head and neck cancer patients with a dismal prognosis live longer than other standard treatments, according to data from a late-stage study presented on Tuesday. -
Obama Wants To Cure Cancer With The Help Of Immunotherapy
President Obama promised to undertake a national effort to cure cancer, a “new moonshot” with Vice President Biden in charge of “mission control.” -
Broccoli Extract Promising For Head And Neck Cancer Prevention
A compound found in broccoli may serve as natural treatment for cancer prevention. -
Researchers Delve Deeper Into HPV-Related Head-And-Neck Cancers
A new study has identified four proteins that play a crucial role in drug-resistant HPV-negative head-and-neck squamous cell cancers, bringing hope to researchers seeking better drug targets. -
Epilepsy Drug Lowers Head And Neck Cancer Risk By 34%
The anticonvulsant and mood-stabilizing drug valproic acid is associated with a 34 percent lower risk of head and neck cancer, a new study finds. -
Adults With Many Cavities Are Less Likely To Develop Head And Neck Cancer
Adults who continuously suffer from cavities may reduce their risk of head and neck cancer.
